- Adults
- General population
- Elderly
- Fragile population
- Hospital wide
- Emergency department
- Infectious diseases unit
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Monoclonal antibodies
- Sotrovimab
- Tixagevimab/Cilgavimab
- Casirivimab/Imdevimab
- Bamlanivimab/ Etesevimab
Population: General population
Individuals who do not belong to a defined subgroup with specific characteristics, representing the broader population
- Adults
- General population
- Elderly
- Fragile population
- Hospital wide
- Emergency department
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Nirmatrelvir/Ritonavir
- Remdesivir
- Monoclonal antibodies
- Sotrovimab
- Adults
- General population
- Elderly
- Outpatient clinic
- Community
- SARS-CoV-2
- Acute SARS-CoV-2
- Pharmacological intervention
- Antivirals
- Remdesivir
- Adults
- General population
- Hospital wide
- Intensive care unit
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute SARS-CoV-2
- Avian Influenza
- Influenza
- Pharmacological intervention
- Immunomodulator
- Baricitinib
- Statins
- Simvastatin
- Adults
- General population
- Hospital wide
- SARS-CoV-2
- Influenza virus
- Influenza A(H5N1) virus
- Acute SARS-CoV-2
- Avian Influenza
- Influenza
- Adults
- General population
- Hospital wide
- Outpatient clinic
- Monkeypox virus
- Monkeypox virus infection
- Adults
- General population
- Community
- Non-hospital health centre
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Primary care
- Monkeypox virus
- Monkeypox virus infection
- Adults
- General population
- Elderly
- Hospital wide
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Adults
- General population
- Hospital wide
- Outpatient clinic
- Monkeypox virus
- Monkeypox virus infection
- Pharmacological intervention
- Antivirals
- Cidofovir
- Adults
- General population
- Elderly
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19
- Non pharmacological intervention
- Rehabilitation
- General population
- Outpatient clinic
- SARS-CoV-2
- Post-COVID-19